TOLL LIKE RECEPTOR-4 GENE ASPARTATE 299 GLYCINE POLYMORPHISM IN SUDANESE PATIENTS WITH MYCETOMA

Mazin Babekir Musa; Ismail Abdalsamad; Najwa. A. Mhmoud; Haghamad Allzain; Sahar M Bakhiet

doi:10.29121/granthaalayah.v9.i2.2021.3492

Authors

Mazin Babekir Musa Department of Microbiology -Faculty of Medical Laboratory Sciences –Shendi University-Sudan https://orcid.org/0000-0001-6519-2996
Ismail Abdalsamad Faculty of Pharmacy- University of Khartoum- Sudan
Najwa. A.Mhmoud Department of Microbiology -Faculty of Medical Laboratory Sciences- University of Khartoum- Sudan
Haghamad Allzain Department of Biochemistry -Faculty of Medicine –Shendi University-Sudan
Sahar M Bakhiet Institute of Endemic Diseases-University of Khartoum- Sudan

DOI:

https://doi.org/10.29121/granthaalayah.v9.i2.2021.3492

Keywords:

Myctoma, DNA, TLR-4, PCR, RFLP, Asp, Gly

Abstract [English]

Background: Mycetoma is a neglected tropical disease characterized by deformity and disabilities with various medical, health, and socioeconomic impacts on the affected communities. The etiological factors associated with Mycetoma have not been fully understood, however genetic predisposition and inflammation are considered as Mycetoma risk factors. Toll like receptors (TLRs) are key players in the innate immune response and play a great role in immune-surveillance and inflammation. This study was conducted to investigate the potential role of TLR4 polymorphism (Asp299Gly) as a risk factor for development of Mycetoma.

Objectives: To determine the presence of TLR4 polymorphism (Asp299Gly) in Sudanese Mycetoma patients as well as measuring allele frequency and genotype distribution of this mutation among Mycetoma patients and healthy controls.

Material and Methods: The current study included ninety five (95) subjects, of whom fifty (50) were confirmed Mycetoma patients and forty five (45) were healthy volunteer controls. It was conducted at the Institute of Endemic Diseases and Mycetoma Research Centre; University of Khartoum in the period, from June 2015 to June 2016. DNA was isolated from blood samples of study subjects and TLR-4 gene polymorphism Asp299Gly was determined using PCR-RFLP with Nco1 restriction enzyme. Genotypes distribution and allele frequencies in the two groups were measured.

Results and conclusion: There was insignificant difference in allele distribution of TLR4 (Asp299Gly) A/G (rs 4986790) in Mycetoma patients compared with the healthy controls. TLR4 (Asp299Gly) polymorphism (rs 4986790) was found in twenty(20) out of fifty (50) Sudanese patients with Mycetoma , that is forty percent (40%) and twenty seven (27) out of forty five (45) healthy control, that is sixty percent (60%).

Further studies are needed in a large and ethnically diverse population to determine the impact of the TLR-4 polymorphism in the susceptibility to Mycetoma.

Downloads

Download data is not yet available.

References

Fahal AH. (2004) Mycetoma thorn on the flesh. Trans R Soc Trop Med Hyg. 98(1) 2. DOI: https://doi.org/10.1016/S0035-9203(03)00009-9

Fahal AH, Hassan MA. (1992) Mycetoma. Br J Surg. 79(11): 1138–1141.

Bonifaz A, Tirado-Sánchez A, Calderón L, Saúl A, Araiza J, et al. (2014) Mycetoma: experience of 482 cases in a single center in Mexico. PLoS Negl Trop Dis. 21; 8(8):e3102 doi: DOI: https://doi.org/10.1371/journal.pntd.0003102

A.H. Fahal, 15May 2003; accepted 4 June 2003: Mycetoma: a thorn in the flesh.

Eduard E Zijlstra, Wendy W J van de Sande, Oliverio Welsh, El Sheikh Mahgoub, Michael Goodfellow, Ahmed H Faha l(Dis 2016) Mycetoma: a unique neglected tropical disease. DOI: https://doi.org/10.1016/S1473-3099(15)00359-X

Medzhitov R. Toll-like receptors and innate immunity. Nat RevImmunol 2001; 1: 135–145. DOI: https://doi.org/10.1038/35100529

Netea M. G., Van der Graaf C., Van der Meer J. W., Kullberg B. J. (2004) Eur. J. Clin. Microbiol. Infect. Dis. 23, 672–676

Levitz S. M. (2010) PLoS Pathog. 6, e1000758.

Mambula S. S., Sau K., Henneke P., Golenbock D. T., Levitz S. M. (2002) J. Biol. Chem. 277, 39320–39326

Netea M. G., Warris A., Van der Meer J. W., Fenton M. J., Verver-Janssen T. J., Jacobs L. E., Andresen T., Verweij P. E., Kullberg B. J. (2003) J. Infect. Dis. 188, 320–326

Netea M. G., Gow N. A., Munro C. A., Bates S., Collins C., Ferwerda G., Hobson R. P., Bertram G., Hughes H. B., Jansen T., Jacobs L., Buurman E. T., Gijzen K., Williams D. L., Torensma R., McKinnon A., MacCallum D. M., Odds F. C., Van der Meer J. W., Brown A. J., Kullberg B. J. (2006) J. Clin. Invest. 116, 1642–1650 DOI: https://doi.org/10.1172/JCI27114

Netea M. G., Van Der Graaf C. A., Vonk A. G., Verschueren I., Van Der Meer J. W., Kullberg B. J. (2002) J. Infect. Dis. 185, 1483–1489

Rodrigo T. FigueiredoPatrícia L. FernandezFabianno F. Dutra, Yissett González, Lívia Cristina LopesVera Carolina B. Bittencourt, Guilherme L. Sassaki, Eliana Barreto-Bergter, and Marcelo T. Bozza (2010 Oct 19) TLR4 Recognizes Pseudallescheria boydii Conidia and Purified Rhamnomannans DOI: https://doi.org/10.1074/jbc.M110.181255

Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25:187-91.

Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the toll like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000;68:6398- 401 DOI: https://doi.org/10.1128/IAI.68.11.6398-6401.2000

N. C. Arbour, E. Lorenz, B. C. Schutte et al., “TLR4 mutations are associated with endotoxin hyporesponsiveness in humans,” Nature Genetics, vol. 25, no. 2, pp. 187–191, 2000. View at Publisher · View at Google Scholar DOI: https://doi.org/10.1038/76048

Wendy W. J. van de Sande, Ahmed Fahal, Henri Verbrugh and Alex van Belkum Polymorphisms in Genes Involved in Innate Immunity Predispose Toward Mycetoma Susceptibility September 1, 2007 vol. 179 no. 5 3065-3074 DOI: https://doi.org/10.4049/jimmunol.179.5.3065

Najwa A. Mhmoud, Ahmed H. Fahal and Wendy W. J. van de Sande The association between the interleukin-10 cytokine and CC chemokine ligand 5 polymorphisms and mycetoma granuloma formation October 28, 2012 DOI: https://doi.org/10.3109/13693786.2012.745201

Lopez-Martinez R, Mendez-Tovar LJ, Bonifaz A, et al. Update on the epidemiology of mycetoma in Mexico. A review of 3933 cases.Gac Med Mex 2013; 149: 586–92 (in Spanish).

Castro LG, Piquero-Casals J. Clinical and mycologic fi ndings and therapeutic outcome of 27 mycetoma patients from Sao Paulo,Brazil. Int J Dermatol 2008; 47: 160–63. DOI: https://doi.org/10.1111/j.1365-4632.2008.03447.x

Ahmed AO, van Leeuwen W, Fahal A, van de Sande W, Verbrugh H, et al. (2004) Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis. 4(9):566–74. DOI: https://doi.org/10.1016/S1473-3099(04)01131-4

M. Koldehoff, D.W. Beelen, A.H. Elmaagacli(3 February 2013) Increased susceptibility for aspergillosis and post-transplant immune deficiency in patients with gene variants of TLR4 after stem cell transplantation DOI: https://doi.org/10.1111/tid.12115

Sellers RM, Payne JB, Yu F, LeVan TD, Walker C, Mikuls TR TLR4 Asp299Gly polymorphism may be protective against chronic periodontitis.2016 Apr;51(2):203-11 DOI: https://doi.org/10.1111/jre.12299

da Silva Santos S, Clark TG, Campino S, Suarez-Mutis MC, Rockett KA, Kwiatkowski DP, Fernandes O. Investigation of host candidate malaria-associated risk/protective SNPs in a Brazilian Amazonian population. 2012;7(5):e36692 DOI: https://doi.org/10.1371/journal.pone.0036692

Hawn TR, Verbon A, Janer M, Zhao LP, Beutler B, Aderem A. Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease. 2005 Feb 15;102(7) DOI: https://doi.org/10.1073/pnas.0409831102